VOLINIA, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 19.186
EU - Europa 3.803
AS - Asia 3.097
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
AF - Africa 4
Totale 26.117
Nazione #
US - Stati Uniti d'America 19.143
CN - Cina 1.473
UA - Ucraina 1.066
TR - Turchia 765
DE - Germania 725
SG - Singapore 667
IT - Italia 600
GB - Regno Unito 431
SE - Svezia 293
FI - Finlandia 261
PL - Polonia 243
ID - Indonesia 92
RU - Federazione Russa 56
FR - Francia 40
CA - Canada 36
BE - Belgio 35
VN - Vietnam 30
IN - India 24
IR - Iran 16
AT - Austria 12
CZ - Repubblica Ceca 10
JP - Giappone 8
NL - Olanda 8
HK - Hong Kong 7
KR - Corea 7
BR - Brasile 6
MX - Messico 6
AU - Australia 5
GR - Grecia 4
LT - Lituania 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
DZ - Algeria 3
ES - Italia 3
CO - Colombia 2
EU - Europa 2
MY - Malesia 2
RS - Serbia 2
SS - ???statistics.table.value.countryCode.SS??? 2
TW - Taiwan 2
BD - Bangladesh 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 26.117
Città #
Fairfield 3.008
Woodbridge 2.710
Houston 1.584
Ashburn 1.297
Jacksonville 1.238
Seattle 1.228
Ann Arbor 1.190
Chandler 1.097
Cambridge 992
Wilmington 991
Singapore 487
Izmir 450
Nanjing 354
Princeton 285
Addison 248
San Diego 241
Warsaw 241
Beijing 227
Boardman 197
Ferrara 178
Milan 130
Nanchang 118
Shanghai 111
New York 104
Shenyang 93
Dearborn 91
Jakarta 91
Los Angeles 89
Hebei 84
Bremen 70
Santa Clara 69
Tianjin 66
Falls Church 63
Mountain View 59
San Mateo 57
Jiaxing 56
Munich 54
Jinan 49
London 47
Redwood City 46
Changsha 45
Kunming 39
Brussels 34
Helsinki 31
Norwalk 31
Dong Ket 30
Ningbo 27
Orange 27
Des Moines 26
Tappahannock 23
Guangzhou 21
Zhengzhou 21
Auburn Hills 20
Taizhou 20
Toronto 18
Hangzhou 17
Philadelphia 16
Hefei 14
Indiana 14
Lanzhou 13
Ottawa 13
Verona 13
Changchun 12
Chicago 12
Ardabil 11
Augusta 11
Redmond 11
Bologna 10
Leawood 10
Vienna 10
Haikou 9
Frankfurt am Main 8
Washington 8
Rome 7
Düsseldorf 6
Hong Kong 6
Andover 5
Ferrara di Monte Baldo 5
Hounslow 5
Mumbai 5
Brno 4
Casalecchio Di Reno 4
Imola 4
Kamagaya Shi 4
Kilburn 4
Nutley 4
Taiyuan 4
Walnut 4
Amsterdam 3
Bonate Sopra 3
Chiswick 3
Edinburgh 3
Faenza 3
Forlì 3
Istanbul 3
Ithaca 3
Kochi 3
L’Aquila 3
Monmouth Junction 3
Naples 3
Totale 20.522
Nome #
Loss of miR-204 expression is a key event in melanoma 168
MicroRNA Expression Signatures in Solid Malignancies 165
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 163
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 160
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 158
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 158
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 153
Identification of microRNA activity by Targets' Reverse EXpression. 150
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. 150
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 148
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 147
null 146
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. 146
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations. 146
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 146
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 145
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 145
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 144
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 143
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 143
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 142
Correlation of expression between different IMAGE clones from the same UniGene cluster 141
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. 141
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 140
null 139
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 137
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 136
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 134
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 134
Microevolution in Ferrara: Isonymy 1890–1990 134
Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. 133
null 132
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 130
MicroRNA expression profiling in human Barrett's carcinogenesis. 130
null 128
null 128
null 128
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 127
null 127
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 127
null 126
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 126
null 126
null 125
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 125
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 124
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 124
null 122
null 121
null 121
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. 121
GAMES identifies and annotates mutations in next-generation sequencing projects 121
null 119
null 119
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. 119
Reprogramming of miRNA networks in cancer and leukemia 117
null 116
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 114
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. 113
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 113
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 113
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 112
CG Dinucleotides of class II MHC genes are mutation hot-spots 112
Expression profiles of craniosynostosis-derived fibroblasts 111
null 111
null 111
Partial gene deletion in a family with factor X deficiency 111
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8 111
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 110
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 110
The role of microRNA genes in papillary thyroid carcinoma 109
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 109
null 108
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 108
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 107
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 106
null 105
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 105
null 104
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 104
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 104
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 104
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 104
null 104
null 103
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 103
Unexpected findings of variability in microRNAs suggest roles in human genetics 103
null 102
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 102
MicroRNA profiles discriminate among colon cancer metastasis 102
null 101
null 101
Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes 101
Physical maps of 4p16.3, the area expected to contain the Huntington disease mutation 100
null 100
null 100
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 100
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 99
null 99
null 99
Totale 12.312
Categoria #
all - tutte 105.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.294
Totale 107.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.014 0 0 0 0 487 738 611 652 570 581 224 151
2020/20214.086 309 406 232 456 275 456 155 510 100 484 479 224
2021/20223.197 174 363 351 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20251.054 155 154 476 211 58 0 0 0 0 0 0 0
Totale 26.476